Sectors Covered   Completed Transactions   Testimonials   Principals   M&A Report 
 and Publications 
 Contact Us 












Dynamic Healthcare M&A Database - 3Q07



Return to the Summary Page (3Q07)



Acquiring Party    Flextronics International Ltd. (NASDAQ:FLEX), a major global provider of electronics manufacturing services.
Transferring Party    Avail Medical Products, Inc., a US based manufacturer of disposable medical devices.
Sector    Medical Devices
Date    August 30, 2007
Analysis
Together with its pending $3.6b Solectron acquisition, buying Avail enhances Flextroinics' medical design, manufacturing and logistics capabilities for disposable medical device products, hand held diagnostics, drug delivery devices and imaging, lab and life sciences equipment. Enables Flextronics to provide customers with accelerated product development and simplified supply chains. Avail's expected '07 sales are $250m. Deal terms not disclosed. (Operating in 20 countries, Solectron is a $10.6b contract manufacturing service company catering to providers of networking, telecommunications, computing, storage, consumer, automotive, industrial, medical, self-service automation and aerospace and defense products.)




The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones.

This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc.


The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.